An essential source of information and analysis on the global atopic dermatitis market. The report identifies the key trends shaping and driving the global atopic dermatitis market, a key segment within the pharma industry.

The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global atopic dermatitis sector.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by our team of industry experts.


Scope

The scope of the report includes:

- Annualized global Atopic dermatitis therapeutics market revenues data from 2001 to 2009, forecast forward for 7 years to 2016.

- Geographies covered in this report include the US, the UK, Italy, Spain, Germany, France, and Japan.

- Pipeline analysis data providing a split across different phases, mechanism of action being developed and emerging trends. Key classes of mechanism of action include Anti-inflammatory molecules, Immunomodulators which included immunosuppresants, NF-kB Inhibitors and blockers, Calcenurin Inhibitors, Inteleukin inhibitors, keratinocyte inhibitors, anti-neoplastics, vaccines, histmaine H1-antagonists, TSLP interaction inhibitors, phosphodiesterase 4 (PDE4) inhibitor, chymase inhibitors, selective glucocorticoid receptor agonist, selective cannabinoid 2 receptor agonist, RAFT Modulator, cytokine modulator and alpha-1 proteinase inhibitors.

- Analysis of the current and future market competition in the global Atopic dermatitis therapeutics market. Key market players covered are Provectus Pharmaceuticals, Barrier Therapeutics and JADO Tehcnologies GmbH.

- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

- Key topics covered include strategic competitor assessment, market characterization, unmet needs and implications for future market associated with Atopic dermatitis.


Reasons to buy

The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to:

- Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.

- Develop business strategies by understanding the trends shaping and driving the global atopic dermatitis market.

- Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global atopic dermatitis market in future.

- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

- What’s the next big thing in the global atopic dermatitis market landscape? – Identify, understand and capitalize.

Table of Contents



40 pages

Publication Date : January 2010